The relationship between opioid and sugar intake: review of evidence and clinical applications

scientific article

The relationship between opioid and sugar intake: review of evidence and clinical applications is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.5055/JOM.2010.0043
P932PMC publication ID3109725
P698PubMed publication ID21269006
P5875ResearchGate publication ID49787192

P2093author name stringMaria A Sullivan
David J Mysels
P2860cites workEvidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intakeQ24651508
Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brainQ33956242
Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosageQ34165672
Sublingual buprenorphine used postoperatively: clinical observations and preliminary pharmacokinetic analysisQ34449382
Impact of opioid use on dentistryQ34760211
Opioid peptides and the control of human ingestive behaviourQ35024658
Leptin attenuates acute food deprivation-induced relapse to heroin seeking.Q48691260
Effects of nalmefene on feeding in humans. Dissociation of hunger and palatabilityQ48907078
Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats.Q48933843
Effect of naltrexone on food intake, hunger, and satiety in obese men.Q48968400
Activation of hypothalamic β-endorphin pools by reward induced by highly palatable foodQ49057792
The response of crying newborns to sucrose: is it a "sweetness" effect?Q51089831
Impaired glucose metabolism in heroin and methadone users.Q51628716
Oral Glucose Tolerance and Hormonal Response in Heroin-dependent MalesQ51678063
Chronic buprenorphine reduces the response to sucrose-associated cues in non food-deprived rats.Q51992432
Taste conditioning effects of buprenorphine in morphine-naive and morphine-experienced rats.Q52186661
Diet and opiate addiction: a quantitative assessment of the diet of non-institutionalized opiate addicts.Q52266751
High sugar intake in a group of women on methadone maintenance in south western Sydney, Australia.Q52273959
Effect of methadone addiction on glucose metabolism in rats.Q52275008
The effects of continuous naltrexone infusions on diet preferences are modulated by adaptation to the dietsQ67487269
Reduction by morphine of human postprandial insulin release is secondary to inhibition of gastrointestinal motilityQ68861121
Interactions between sucrose, pain and isolation distressQ69002105
High-dose naltrexone therapy and dietary counseling for obesityQ69685502
A controlled trial of naltrexone in obese humansQ69922274
The cold pressor test in children: methodological aspects and the analgesic effect of intraoral sucroseQ72007011
Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eatersQ72267762
Voluntary consumption of ethanol in 15 inbred mouse strainsQ72579770
Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjectsQ73878575
Modulation of morphine-induced antinociception by palatable solutions in male and female ratsQ74014982
Preference for sweet foods and higher body mass index in patients being treated in long-term methadone maintenanceQ81400675
Oral sucrose and pain relief for preterm infantsQ35167032
Hyperglycaemia produced by drugs with analgesic properties introduced into the cerebral ventricles of catsQ35175317
Pediatric obesity: parallels with addiction and treatment recommendationsQ35961441
Opioid-induced gastrointestinal dysfunctionQ36478105
Neural mechanisms underlying obesity and drug addictionQ36733112
Dentition of addiction in Queensland: poor dental status and major contributing drugsQ36905688
Methadone: dental risks and preventive actionQ37340841
Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addictsQ37492094
Nutritional effects of marijuana, heroin, cocaine, and nicotineQ37951945
General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditionsQ38288915
Naltrexone reduces weight gain, alters "beta-endorphin", and reduces insulin output from pancreatic islets of genetically obese miceQ38357225
Antinociceptive effects of palatable sweet ingesta on human responsivity to pressure painQ38559359
Opioids in the regulation of food intake and energy expenditure.Q39754543
Opioid regulation of food intake and body weight in humansQ39754554
Primary care affiliations of adults in a methadone program with onsite careQ39794063
The narcotic addict as a medical patientQ39974333
Morphine, Opioid Peptides, and Pancreatic Islet FunctionQ40172506
A new look at some old mechanisms in human newborns: taste and tactile determinants of state, affect, and actionQ40681238
Intake of and preference for sweet solutions are attenuated in morphine-withdrawn ratsQ41132060
Psychoneuroendocrine effects of methadone maintenanceQ41256508
"Sucrose analgesia": absorptive mechanism or taste perception?Q42029350
Effect of non-sucrose sweet tasting solution on neonatal heel prick responsesQ42042151
Reduction of pain response in premature infants using intraoral sucroseQ42206110
Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placeboQ43257234
Methylnaltrexone reduced body weight gain in ob/ob mice.Q43279734
Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbensQ43874245
Age-dependency of analgesia elicited by intraoral sucrose in acute and persistent pain modelsQ44006929
Taste function in methadone-maintained opioid-dependent men.Q44094329
Alterations in food intake elicited by GABA and opioid agonists and antagonists administered into the ventral tegmental area region of ratsQ44100140
Effects of buprenorphine on candy and sweetened fluid self-administration by rhesus monkeysQ44196915
Tolerance to morphine analgesia from brief exposure to a palatable solutionQ44281831
Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa opioid antagonists in the hypothalamic paraventricular nucleus of ratsQ44334094
Effects of opioid blockade on the modulation of pain and mood by sweet taste and blood pressure in young adultsQ44335289
Activation of mesolimbic dopamine neurons during novel and daily limited access to palatable food is blocked by the opioid antagonist LY255582.Q44339011
The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeysQ44463347
Effects of chewing gum on responses to routine painful procedures in childrenQ44497114
Beta-endorphin concentration after administration of sucrose in preterm infantsQ44650369
Taste modulation of nociception differently affects chronically stressed ratsQ44740603
Nutritional status of deceased illicit drug addicts in Stockholm, Sweden--a longitudinal medicolegal study.Q44803279
Opiate-like effects of sugar on gene expression in reward areas of the rat brainQ44890065
Dopamine for "wanting" and opioids for "liking": a comparison of obese adults with and without binge eatingQ46090258
Rational design of a combination medication for the treatment of obesityQ46255375
An intriguing association between dental and mental pathology in addicted and control subjects: a cross-sectional surveyQ46294271
Assessment of daily nutrition ratios of opiate-dependent persons before and after 4 years of methadone maintenance treatmentQ46752895
Effects of long-term therapy with naltrexone on body weight in obesityQ47219869
Nonketotic hyperglycemic coma in toddlers after unintentional methadone ingestionQ48414416
Naltrexone and human eating behavior: a dose-ranging inpatient trial in moderately obese men.Q48483962
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)445-452
P577publication date2010-11-01
P1433published inJournal of Opioid Management: a medical journal of proper and adequate useQ15762496
P1476titleThe relationship between opioid and sugar intake: review of evidence and clinical applications
P478volume6

Reverse relations

cites work (P2860)
Q33912776Additive burdens of malnutrition, poverty, and substance abuse
Q38602786Association between Tooth Loss and Opium Addiction: Results of a Community-Based Study on 5900 Adult Individuals in South East of Iran in 2015.
Q89877491Association of prescription opioids and incident cardiovascular risk factors among post-9/11 Veterans
Q47140416Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors.
Q60637900Characteristics of Medicaid recipients in Methadone Maintenance Treatment: A comparison across the lifespan
Q42227752Chronic hepatitis C in Swedish subjects receiving opiate substitution therapy--factors associated with advanced fibrosis.
Q90609333Comparing Medical Comorbidities Between Opioid and Cocaine Users: A Data Mining Approach
Q40906623Comparison of acute effects of heroin and Kerack on sensory and motor activity of honey bees (Apis mellifera).
Q89635315Dental caries and periodontal disease among people who use drugs: a systematic review and meta-analysis
Q99713341Effect of Opioid Use on Immune Activation and HIV Persistence on ART
Q38156648Effect of taste sensation on cough reflex sensitivity
Q36629106Effect of the co-administration of glucose with morphine on glucoregulatory hormones and causing of diabetes mellitus in rats
Q47269773Feeding Releases Endogenous Opioids in Humans.
Q35093247Feeding and reward: perspectives from three rat models of binge eating
Q46168285Hypertension, chronic obstructive pulmonary disease, diabetes and depression among older methadone maintenance patients in British Columbia
Q30685091Illicit drug use and cardiometabolic disease risk: an analysis of 2005-2008 National Health and Nutrition Examination Survey data
Q35137700Increases in body mass index following initiation of methadone treatment
Q35033778Inflated reward value in early opiate withdrawal
Q48462856Is biological aging accelerated in drug addiction?
Q44330869Longitudinal Analysis of Opioid Analgesic Dose and Diabetes Quality of Care Measures
Q90714102Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone
Q38644786Metabolic syndrome among individuals with heroin use disorders on methadone therapy: prevalence, characteristics, and related factors
Q33897658Opioid use disorder and type 2 diabetes mellitus: Effect of participation in buprenorphine-naloxone substitution programs on glycemic control
Q39161561Pain Relief in Nonhuman Primate Models of Arthritis
Q30439299Reduced emotional signs of opiate withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake
Q46486319Serum biochemical parameters following heroin withdrawal: an exploratory study.
Q39013270Substance Use Disorders among Patients with Type 2 Diabetes: a Dangerous but Understudied Combination
Q47400217Sweet taste pleasantness is modulated by morphine and naltrexone
Q47656576The cardio-metabolic impact of taking commonly prescribed analgesic drugs in 133,401 UK Biobank participants.
Q91842292The need for further oral health research surrounding the provision of dental treatment for people with drug dependency
Q92534027Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: A needs assessment for decision making support